GlassScriptPhysician profile
Frederick N Fedorchak
NPI 1184662496
$552.38
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $231 · 2020: $27.80 · 2021: $206 · 2022: $87.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $213.28 | 2019-2020 | |
| Stryker Corporation | $160.59 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $66.67 | 2021 | |
| Alfasigma USA, INC. | $26.72 | 2021 | |
| Horizon Therapeutics Plc | $22.36 | 2021 | |
| Abbvie INC. | $19.22 | 2019 | |
| Abbott Laboratories | $17.63 | 2021 | |
| Amgen INC. | $14.36 | 2019 | |
| Janssen Biotech, INC. | $11.55 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Fedorchak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.